Unexpected Improvement of Cystoid Macular Edema in Pediatric Usher Syndrome 1B

Overview

A 3-year-old male with genetically confirmed Usher syndrome type 1B presented with bilateral cystoid macular edema (CME) and was managed conservatively with refractive correction alone. Over 9 months, spontaneous and sustained resolution of CME was observed alongside accelerated axial elongation, highlighting potential intrinsic retinal recovery in pediatric USH1B.

Background

Usher syndrome type 1 (USH1) is a severe autosomal recessive disorder characterized by early-onset retinitis pigmentosa (RP), profound sensorineural hearing loss, and vestibular dysfunction. RP leads to progressive vision loss starting with night blindness and peripheral field constriction, often complicated by cystoid macular edema (CME) in 10–50% of cases. CME represents a treatable cause of vision loss in RP, but its pathophysiology and management, especially in children, remain poorly understood. USH1B is caused by mutations in the MYO7A gene, with variable phenotypic expression.

Data Highlights

Key Findings

• Genetic testing confirmed compound heterozygous pathogenic variants in MYO7A, consistent with USH1B diagnosis.
• Baseline ophthalmic exam showed bilateral CME with large cystoid spaces in multiple retinal layers and partial ellipsoid zone disruption but relatively intact foveal EZ.
• Conservative management with refractive correction alone led to spontaneous and sustained resolution of CME over 9 months.
• Accelerated axial elongation was observed during the follow-up period, though its relationship to USH1B is unclear.
• No cataracts or bone spicule pigmentation were observed at baseline, and visual acuity improved with correction.

Clinical Implications

This case suggests that pediatric patients with USH1B-associated CME may experience spontaneous resolution without pharmacologic intervention, emphasizing the importance of individualized treatment decisions. Conservative management with refractive correction may be a viable initial approach, avoiding potential risks of invasive therapies in young children. Monitoring axial length changes may provide additional insights into ocular development in USH1B.

Conclusion

The unexpected improvement of CME in a child with USH1B highlights potential intrinsic retinal recovery mechanisms and supports cautious, individualized management strategies in pediatric RP-associated CME. Further studies are needed to elucidate the relationship between axial elongation and USH1B progression.

References

1. Introduction and Case Report -- Unexpected Improvement of Cystoid Macular Edema Accompanied by Axial Elongation in a Child with Usher Syndrome Type 1B